Cisplatin and etoposide for metastatic testis cancer in a renal transplant recipient.
We report on a patient with a transplanted kidney and metastatic testicular cancer who received 4 cycles of cisplatin and etoposide. The patient experienced no renal toxicity and was free of disease after 5 years. Patient management issues are discussed.